We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Epidural Stimulation Improves Paraplegic CV Function

By HospiMedica International staff writers
Posted on 05 Mar 2018
A new study suggests that epidural neuroprosthetics may alleviate cardiovascular dysfunction in people with chronic spinal cord injury (SCI).

Researchers at the University of British Columbia (UBC; Vancouver, Canada) conducted an experimental study in a man in his early 30’s with a chronic C5 motor-complete SCI to investigate if lumbosacral epidural stimulation could be optimized so as to control cardiovascular functions, especially blood pressure (BP). More...
The patient was fitted with an epidural spinal cord stimulation unit and implanted with the Medtronic Specify 5-6-5 electrode array at T11-L1 vertebral levels, with placement confirmed via radiography.

A series of tests were undertaken to determine the optimum stimulation parameters to increase BP in the seated position. On the main experimental day, the researchers assessed beat-by-beat BP via finger photoplethysmography, cardiac function using transthoracic echocardiography, cerebral blood flow and neurovascular coupling by transcranial Doppler, and trunk/lower-limb electromyography. All procedures were initially assessed in the supine position and then in response to a 60° head-up tilt, both with and without epidural stimulation. The patient then applied different programs for up to 45 minutes each day, transmitting electrical impulses that mimicked signals emanating from the brain.

The results revealed that stimulation resolved the orthostatic hypotension, a debilitating and prevalent condition in SCI, with the rise in BP in response to stimulation well controlled. In addition, stimulation prevented orthostatic-induced decrease in middle cerebral artery blood flow, improved neurovascular coupling, and resolved orthostatic-induced symptoms, including light-headedness, dizziness, and poor concentration that were self-reported without stimulation. The stimulation also prevented reduction in end-diastolic volume during tilt, thereby preserving stroke volume and cardiac output. The study was published on February 19, 2018, in JAMA Neurology.

"Mobility issues or paralysis are the most visible consequences of a spinal cord injury, but as a clinician, I know that many of my patients suffer from other 'invisible' consequences. Many of my patients have abnormal blood pressure and bladder, bowel, and sexual dysfunctions that can be quite devastating,” said senior author Professor Andrei Krassioukov, MD, PhD. “These preliminary data suggest that epidural neuroprosthetics may provide an important complement to pharmacological agents that are often slow-acting with undesirable adverse effects.”

The Medtronic Specify 5-6-5 system is composed of 16 electrodes in a three-column configuration that offers overlapping areas of stimulation, therefore maximizing the impact of spinal cord stimulation. The tripolar lead configuration and stimulation patterns can potentially help in surpassing restrictions of earlier approaches to spinal cord stimulation, especially for axial pain.

Related Links:
University of British Columbia


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hybrid Arch Device
Neo EDE
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.